Natus Receives 510(k) FDA Clearance for the Quantum High Channel Count Amplifier
April 21 2015 - 7:00AM
Natus Medical Incorporated (Nasdaq:BABY) announced
today that it has received FDA 510(k) clearance for the Quantum
amplifier; an innovative high channel count amplifier that has
applications in epilepsy and seizure monitoring along with research
applications.
Quantum is the first amplifier in the market to offer up to 256
channels in a compact, wearable package. Quantum is also the first
compact amplifier to feature up to 16 kHz sampling rates providing
increased visibility of faster brain frequencies combined with a
software controlled Digital Switch Matrix facilitating functional
brain mapping through cortical stimulation and a dual data stream
for an efficient clinical and research workflow. The Quantum
amplifier combined with Natus Neuroworks software produce an
enhanced user experience resulting in improved patient care.
The Quantum amplifier compliments our market leading
neurodiagnostic product line in use today by epilepsy centers, EEG
labs, sleep disorder centers, emergency rooms and intensive care
units worldwide.
"Natus is committed to working with healthcare providers and
leading academic institutions to develop breakthrough solutions and
improve patient care. This new product is a quantum leap in
amplifier technology and is a great example of our commitment,"
said Jim Hawkins, CEO and President of Natus Medical
Incorporated.
Quantum will be featured at the Natus Neurology booth at the
American Academy of Neurology (AAN) and at the American Epilepsy
Society (AES) meetings as well as other leading US &
International trade shows throughout the year.
About Natus Medical
Natus is a leading provider of healthcare products used for the
screening, detection, treatment, monitoring and tracking of common
medical ailments in neurological dysfunction, newborn care and
hearing impairment.
Additional information about Natus Medical can be found at
www.natus.com.
CONTACT: Company Contact:
Natus Medical Incorporated
Jonathan A. Kennedy
Sr. Vice President Finance and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com
PishPosh (NASDAQ:BABY)
Historical Stock Chart
From Jun 2024 to Jul 2024
PishPosh (NASDAQ:BABY)
Historical Stock Chart
From Jul 2023 to Jul 2024